Article info
PDFExtended report
Radiographic progression in patients with ankylosing spondylitis after 2 years of treatment with the tumour necrosis factor α antibody infliximab
- Correspondence to:
Professor J Braun
Rheumazentrum Ruhrgebiet, Landgrafenstr15, 44652 Herne, Germany; j.braunrheumazentrum-ruhrgebiet.de
Citation
Radiographic progression in patients with ankylosing spondylitis after 2 years of treatment with the tumour necrosis factor α antibody infliximab
Publication history
- Accepted March 14, 2005
- First published March 18, 2005.
Online issue publication
April 17, 2023
Article Versions
- Previous version (25 October 2017).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Copyright 2005 by Annals of the Rheumatic Diseases